Cell Genesys reports vaccine data
Cell Genesys today reported encouraging clinical data from a Phase II trial of GVAX vaccine for chronic myelogenous leukemia. Release [1]
Links:
[1] http://www.fiercebiotech.com/press-releases/cell-genesys-reports-positive-results-phase-2-trial-gvax-r-vaccine-leukemia-chronic-m